AI-generated summary
The authors studied vascular tissue around hydroxyapatite orbital implants in a rabbit model treated with low-level laser therapy, using high-throughput sequencing to find differentially expressed microRNAs. They report that miR-90 was predicted to bind VEGFA, that this targeting was confirmed experimentally, and that miR-90 inhibited rabbit microvascular endothelial cell proliferation, migration and tube formation in vitro. The work was done in animal tissue and cultured cells, so the findings may not apply directly to patients.
- Who or what was studied
- Rabbit hydroxyapatite orbital implant model and rabbit microvascular endothelial cells
- Limits stated in the abstract
- The study used an animal model and cultured cells, and the abstract does not report a human sample or clinical outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Angiogenesis, Wound healing, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.